Schonfeld Strategic Advisors LLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$42,000
-41.7%
10,800
-28.5%
0.00%
-100.0%
Q1 2022$72,00015,1000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders